Loading
Latest filing published 15 Apr 2025 for Assembly Biosciences, INC., €6,891. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of John G. McHutchison in Assembly Biosciences, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 9 August 2021 to 31 March 2025, the count stands at 8 filings.
Every open-market trade on record is a sale: 6 sales worth €125k. Besides market trades, the filings include 2 share grants. 2025 to date brings no purchases and 1 sale.
The record was last updated on 15 April 2025 with an open-market sale (€6,891) in Assembly Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations